Short report: Care for children and adolescents with diabetes in Australia and New Zealand: Have we achieved the defined goals?

Journal of Paediatrics and Child Health

Volumn 49, Issue 4, 2013, Pages

  Cameron, Fergus ^a   Cotterill, Andrew ^b   Couper, Jennifer ^c,e   Craig, Maria ^d,f   Davis, Elizabeth ^h,i   Donaghue, Kim ^d   Jones, Timothy ⁱ   King, Bruce ^g   Sheil, Barbara ^j  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MATER CHILDREN S HOSPITAL   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g UNIVERSITY OF NEWCASTLE   (Australia)

^h JOHN HUNTER CHILDREN S HOSPITAL   (Australia)

ⁱ PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^j UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA AND NEW ZEALAND; CHILD CARE; DIABETES MELLITUS; HOSPITAL PERSONNEL; HUMAN; NOTE; PRIORITY JOURNAL;

ADOLESCENT; AUSTRALIA; CHILD; CHILD, PRESCHOOL; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; HEALTH MANPOWER; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFANT; INFANT, NEWBORN; NEW ZEALAND; QUALITY ASSURANCE, HEALTH CARE;

EID: 84876280613     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/jpc.12145     Document Type: Note

References (28)

1. Group TDR. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J. Pediatr. 1994; 125: 177-188.
2. White NH, Cleary PA, Dahms W, et al. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J. Pediatr. 2001; 139: 804-812.
3. Kelly H, Jones T, Byrne G,. Diabetes-national action plan. Med. J. Aust. 1993; 159: 838.
4. Couper JJ, Jones TW, Donaghue KC, et al. The Diabetes Control and Complications Trial. Implications for children and adolescents. Australasian Paediatric Endocrine Group. Med. J. Aust. 1995; 162: 369-372.
5. Delamater AM,. Psychological care of children and adolescents with diabetes. Pediatr. Diabetes 2009; 10 (Suppl. 12): 175-184.
6. Spinks JJ, Haest J, Ross K, et al. Paediatric Diabetes Services-evidence that expanding the workforce allows intensification of insulin regimens and improves glycaemic control. Arch. Dis. Child. 2009; 94: 646-647.
7. Karvonen M, Viik-Kajander M, Moltchanova E, et al. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 2000; 23: 1516-1526.
8. Federation ID,. Diabetes Atlas, 2nd edn. Brussels, Belgium: IDF, 2003.
9. Haynes A, Bower C, Bulsara MK, et al. Continued increase in the incidence of childhood Type 1 diabetes in a population-based Australian sample (1985-2002). Diabetologia 2004; 47: 866-870.
10. Catanzariti L, Faulks K, Moon L, et al. Australia's national trends in the incidence of Type 1 diabetes in 0-14-year-olds, 2000-2006. Diabet. Med. 2009; 26: 596-601.
11. Ma RC, Chan JC,. Diabetes: incidence of childhood type 1 diabetes: a worrying trend. Nat. Rev. Endocrinol. 2009; 5: 529-530.
12. Australian Institute of Health and Welfare. Prevalence of Type 1 diabetes in Australian children, 2008. Diabetes series. 2011; No. 15. 2011 A.
13. Tamborlane WV, Bonfig W, Boland E,. Recent advances in treatment of youth with Type 1 diabetes: better care through technology. Diabet. Med. 2001; 18: 864-870.
14. McMahon SK, Airey FL, Marangou DA, et al. Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life. Diabet. Med. 2005; 22: 92-96.
15. Vardi M, Jacobson E, Nini A, Bitterman H,. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database Syst. Rev. 2008; (3): CD006297.
16. Langendam MW, Hooft L, De Vries H, et al. Continuous glucose monitoring systems for type 1 diabetes mellitus. Cochrane Database Syst. Rev. 2009; (3): CD008101.
17. Australian Institute of Health and Welfare. Australia's health 2010. Australia's Health. No. 12. 2010 A.
18. Rewers M, Pihoker C, Donaghue K, et al. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr. Diabetes 2009; 10 (Suppl. 12): 71-81.
19. Pihoker C, Forsander G, Wolfsdorf J, et al. The delivery of ambulatory diabetes care to children and adolescents with diabetes. Pediatr. Diabetes 2009; 10 (Suppl. 12): 58-70.
20. Sjöblad S,. Pediatric and Adolescent Diabetes. A National Care Program by the Swedish Society for Diabetology and Endocrinology. Lund: Studentlitteratur, 2008.
21. Swift PG, Skinner TC, de, Beaufort CE, et al. Target setting in intensive insulin management is associated with metabolic control: the Hvidoere childhood diabetes study group centre differences study 2005. Pediatr. Diabetes 2010; 11: 271-278.
22. Lin A, Northam EA, Rankins D, et al. Neuropsychological profiles of young people with type 1 diabetes 12 yr after disease onset. Pediatr. Diabetes 2010; 11: 235-243.
23. American Diabetes Association. Executive summary: standards of medical care in diabetes-2011. Diabetes Care 2011; 34 (Suppl. 1): S4-10.
24. American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care 2011; 34 (Suppl. 1): S11-61.
25. Craig ME, Twigg SM, Donaghue KC, et al. for the Group ATDGEA. National evidence based clinical care guidelines for type 1 diabetes in children, adolescents and adults. Australian Government Department of Health and Ageing, Canberra. 2011.
26. Chalew S,. Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes: response to de Beaufort et al. Diabetes Care 2008; 31: e27; author reply e28.
27. Bulsara MK, Holman CD, Davis EA, et al. The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1 diabetes. Diabetes Care 2004; 27: 2293-2298.
28. de Boer IH, Sun W, Cleary PA, et al. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N. Engl. J. Med. 2011; 365: 2366-2376.